RXRX
Recursion Pharmaceuticals, Inc.
$3.01
AlphaVal Unavailable
AlphaVal: RXRX has had negative net income and negative EPS in all 5 available fiscal year(s). Quality gate: persistently unprofitable companies are excluded.